Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Evaluation of liquid formulations of Bt against gram pod borer, Helicoverpa armigera (Hubner) and spotted pod borer, Maruca vitrata (Geyer) in pigeonpea

G. V. Suneel Kumar, L. Vijaya Bhaskar, Y. Satish, S. J. Rehaman.




Abstract
Cited by 4 Articles

A field experiment was conducted during 2012-13, 2013-14 and 2014-15 at Agricultural Research Station, Darsi, Prakasam district, Andhra Pradesh to evaluate Bt liquid formulations and other biopesticides against gram pod borer, Helicoverpa armigera and spotted pod borer, Maruca vitrata in pigeonpea. There were 10 treatments (2 strains of Bt liquid formulation each at two doses, powdered Bt formulation, two doses of Beauvera bassiana, neem formulation, chemical check) including untreated control. Pooled analysis of three years data revealed that two sprays of chlorpyriphos 0.25% at fortnightly interval was significantly superior over other treatments in suppressing the larval population of H. armigera (av. 0.81 larvae/plant) and M. vitrata (av. 0.80 larvae/ inflorescence) on pigeon pea and recorded minimum pod (5.07%) and seed (3.24 %) damage with maximum 16.9 q/ha yield. It was however, at par with the Bt strain NBAII-BtG4 @ 2% in respect of pod damage (5.30%), seed damage (3.91%) and yield (15.3 q/ha). The Bt strain NBAII-BtG4 @ 2% ranked next best to the insecticidal spray in recording surviving larval population of H. armigera (av. 1.01 larvae / plant) and M. vitrata (av. 1.10 larvae / inflorescence). Moreover, the treatment PDBC-BT1 @ 2% was also found to be equally effective to superior ones. It is therefore biopesticides should be encouraged as eco-friendly insecticides.

Key words: KEYWORDS: Bt liquid formulations, Biopesticides, Eco-friendly management, Helicoverpa armigera, Maruca vitrata, Pigeonpea.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.